Showing results (101-110 of 155) with videos related to
Sort By:
Pageof 16
Journal of Drugs in Dermatology : JDD|February 21, 2018
Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEILLinda Stein Gold, Jerry Bagel, Mark Lebwohl, et al.Journal of Cutaneous Medicine and Surgery|September 28, 2010
Treatment decision needs of psoriasis patients: cross-sectional surveyJerry Tan, Dawn Stacey, Karen Fung, et al.Cutis|September 15, 2009
A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acneLinda Stein Gold, Jerry Tan, Alma Cruz-Santana, et al.American Journal of Clinical Dermatology|March 24, 2021
Rosacea: New Concepts in Classification and TreatmentEsther J van Zuuren, Bernd W M Arents, Mireille M D van der Linden, et al.International Journal of Dermatology|November 18, 2024
One Acne™: A holistic management approach to improve overall skin quality and treatment outcomes in acne with or without sensitive skinLeon Kircik, Jerry Tan, Edward Ted Lain, et al.Dermatology and Therapy|March 23, 2023
Narrative Review of the Pathogenesis of Stasis Dermatitis: An Inflammatory Skin Manifestation of Venous HypertensionJonathan Silverberg, J Mark Jackson, Robert S Kirsner, et al.Clinical, Cosmetic and Investigational Dermatology|July 17, 2023
A Dermocosmetic Significantly Reduces the Frequency and Intensity of Facial Skin Intolerability and Sensitivity in Subjects with Skin Intolerant to Skin Care Products and Sensitive SkinDelphine Kerob, Anna Czermanska, Ewa M Karamon, et al.Dermatology Online Journal|December 20, 2020
Development of a hidradenitis suppurativa patient decision aidOlivia McBride, Donna McLean, Tanja Samardzic, et al.Journal of Drugs in Dermatology : JDD|August 16, 2017
Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL StudyBruce Strober, Jerry Bagel, Mark Lebwohl, et al.Journal of Drugs in Dermatology : JDD|March 6, 2014
Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studiesLinda Stein, Leon Kircik, Joseph Fowler, et al.Pageof 16